학술논문
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis
Document Type
Article
Author
Source
In Bone 2011 49(5):939-943
Subject
Language
ISSN
8756-3282